About this trial
Micro and nanoplastics (MNPs) are environmental contaminants found in food and water. Recent evidence suggests these particles may be linked to intestinal inflammation and changes in gut bacteria, which are key features of Crohn's Disease (CD). This study aims to investigate if patients with Crohn's Disease have a reduced ability to clear these plastic particles and how this affects their immune system and intestinal health.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-80 years
Confirmed diagnosis of Crohn's disease (for cases)
Ability to provide informed consent.
Age 18-80 years old
Disqualifiers
Antibiotic/probiotic use within 4 weeks
History of gastrointestinal malignancy
Presence of stoma
Currently Pregnant
Trial population
Potential subjects will be identified at the Department of Medicine and Therapeutics of the Prince of Wales Hospital, or by personal referral from staff.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Micro- and nanoparticle abundance between subjects with Crohn's Disease and controls
Blood sample and intestinal biopsy specimens will be collected to perform micro and nanoplastics quantification.
Secondary outcomes
Plastic-degrading gene [PDG] abundance between subjects with Crohn's Disease and controls.
Blood and stool samples, as well as intestinal biopsy specimens will be collected to perform fecal DNA extraction, metagenomic sequencing and Plastic-Degrading Genes (PDG) analysis.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mak Wing Yan
Lead sponsor
Chinese University of Hong Kong
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: